SCHEMBL6496471

SCHEMBL6496471

COC(=O)c1c(C)cccc1COc1cc(C)c2nc(C)n(Cc3ccc(-c4ccccc4)cc3Cl)c2c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 2/20 0.37
PIK3C2B O00750 2/20 0.36
MAPT P10636 4/20 0.36
TP53 P04637 1/20 0.36
BCL2 P10415 3/20 0.35
MCL1 Q07820 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
CD274 Q9NZQ7 2/20 0.35
PPARG P37231 1/20 0.35
ALOX5AP P20292 2/20 0.35
AR P10275 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90B1 P14625 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492529 0.95 PIK3C2B (0.38) DCTPP1PIK3C2BMAPTTP53BCL2
SCHEMBL6488013 0.93 BDKRB1 (0.36) DCTPP1PIK3C2BMAPTTP53BCL2
SCHEMBL6498346 0.93 CD274 (0.37) DCTPP1PIK3C2BMAPTTP53BCL2
SCHEMBL6500643 0.93 ALOX5AP (0.40) DCTPP1PIK3C2BBCL2MCL1ALOX5AP
SCHEMBL6498787 0.91 BCL2 (0.40) DCTPP1PIK3C2BMAPTTP53BCL2
SCHEMBL6499859 0.90 DCTPP1 (0.42) DCTPP1PIK3C2BBCL2MCL1AR
SCHEMBL6502905 0.89 PIK3C2B (0.41) DCTPP1PIK3C2BBCL2MCL1ALOX5AP
SCHEMBL6498230 0.87 ALOX5AP (0.38) DCTPP1MAPTTP53BCL2MCL1
SCHEMBL6488163 0.87 PIK3C2B (0.37) DCTPP1PIK3C2BMAPTTP53BCL2
SCHEMBL6498198 0.87 DCTPP1 (0.47) DCTPP1MAPTBCL2MCL1ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD DCTPP1 1534/4885PIK3C2B 2433/4885MAPT 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.